Building a leading microbiome

company in oncology

We are a clinical-stage microbiome therapeutics company
aiming to improve survival in cancer.

Our strengths

A full ecosystem approach

Oncology focused

AI-Powered Drug Development

cGMP Versatile Manufacturing Capacities

Latest News

October 15, 2021

MaaT Pharma espère lever entre 35 et 46 millions d’euros en Bourse

October 15, 2021

Microbiote : MaaT Pharma se lance en Bourse

October 15, 2021

MaaT Pharma launches its initial public offering on the regulated market of Euronext in Paris

Like what you see? See more posts

Join the MaaT Pharma adventure!

Bring your talents, your passion and join an inclusive, creative, and multidisciplinary team. We aim to leverage the potential of microbiome to improve the treatment of patients with cancer.

Learn more about our values, our environment and see what we have to offer to you!